Phone number: +86 02259096488 23 36 invasive prenatal diagnosis, which was interpreted in a blinded fashion. Three fetuses 37 were identified as compound heterozygosity of MMACHC, 9 fetuses were carriers of 38 MMACHC variant, and 9 fetuses were normal. These results indicated that the 39 haplotype-based NIPT for MMA through small target capture region sequencing is 40 technically accurate and feasible. 41 42
0 Abstract: 24 Methylmalonic acidemia (MMA) cblC type is the most frequent inborn error of 25 intracellular cobalamin metabolism which is caused by mutations of MMACHC gene. 26 Non-invasive test of MMA for pregnant women facilitates safe and timely prenatal 27 diagnosis of the disease. In our study, we aimed to design and validate a 28 haplotype-based noninvasive prenatal test (NIPT) method for cblC type of MMA. 29 Targeted capture sequencing using customized hybridization was performed utilizing 30 gDNA (genomic DNA) of trios including parents and an affected proband to 31 determine parental haplotypes associated with the mutant and wild allele. The fetal 32 haplotype was inferred later based on the high depth sequencing data of maternal 33 plasma as well as haplotype linkage analysis. The fetal genotypes deduced by NIPT 34 were further validated by amniocentesis. Haplotype-based NIPT was successfully 35 performed in 21 families. The results of NIPT of 21 families were all consistent with 1 Introduction 43 Methylmalonic acidemia (MMA) is caused by a deficiency of methylmalonyl-coA 44 mutase or coenzyme adenosylcobalamin (AdoCbl). The cblC type combined with 45 methylmalonic acidemia and homocystinuria is a kind of autosomal recessive 46 hereditary disease and the incidence was found to be in 1 in 48,000 to 1 in 250,000 47 worldwide (Carrillo-Carrasco et al. 2012; Wang et al. 2010) . Newborn screening for 48 MMA in Shandong province of China showed an estimated prevalence of 1 in 3920 49 during birth (Han et al. 2016) . The MMA cblC type caused by mutations in the 50 MMACHC gene (NM_015506.2) located on chromosome 1p34.1 is the most frequent 51 congenital error in intracellular co-amine metabolism. Prenatal diagnosis of MMA 52 was essential due to age of onset in neonatal period and serious symptoms such as 53 multiple system damage and lethal possibility. It can not only contribute to early 54 medical management of infants, but also allows treatment of affected foetus as soon 55 as possible to reduce irreversible organ damage associated with metabolic acidosis 56 and high blood ammonia. (Huemer et al. 2005; Trefz et al. 2016) . 57 Recently, several noninvasive prenatal test (NIPT) methods aimed to avoid 58 miscarriage or infection risk method have been developed (Evans et al. 2002; 59 Mujezinovic and Alfirevic 2007). Besides large-scale clinical application in fetal 60 aneuploidies screening, NIPT for dominant single-gene disorders confined to detect 61 paternally inherited and de novo mutations has also been introduced to clinical trials 62 (Lo et al. 1998; Fan et al. 2008) . However, NIPT for recessive single gene disorders 63 are still at laboratory research stage. Our study group has developed a 64 haplotype-based method of NIPT for recessive inherited single gene diseases using 65 linkage analysis of trios' members and has been validated in several single gene 66 disorders (Xu et al. 2015; Meng et al. 2014; Lam et al. 2012; Ma et al. 2014; Ye et al. 67 2 2018; Chen et al. 2017) . The feasibility and accuracy of this method depends on the 68 informative SNPs used to construct the haplotype and the selection of the targeted 69 region. NIPT of MMA based on haplotype analysis method has not been reported yet, 70 and so this study has been designed. 71 In our study, the NIPT of MMA can be accomplished using a 141.39 kb 72 customized probe, including MMACHC and 1125 surrounding highly heterozygous 73 SNPs (0.3＜minor allele frequency＜0.5) distributed within the 1 Mb on chromosome 74 1 ( Figure 1 ). Our study indicated that the haplotype-based NIPT for MMA through 75 small target capture region sequencing is technically accurate and feasible, and also 76 further highlighted the feasibility of NIPT of monogenic diseases. The raw data were aligned to the human reference sequence (Hg19, GRCh37) by 104 BWA software (0.7.12) in the paired end mode. After removal of low-quality reads 105 including duplicated reads and multiple aligned reads using Picard Tools, Variation 106 calling was accomplished through GATK software. Only the variations with depth 107 greater than 50x will be analyzed in the next step. Hap 0 was defined as the pathogenic haplotype and Hap1 was defined as the 118 wild-type haplotype. The fetal inheritance from father was determined using the set of 119 SNPs that were heterozygous in father but homozygous in mother. SNPs that were 120 heterozygous in mother but homozygous in father were used to determine fetal 121 inheritance from mother. Hidden Markov Model (HMM) and Viterbi algorithm was 122 used to deduce the fetal haplotypes using the target region data of plasma (Ma et al. The parental haplotype was constructed by the genotyping information from a 144 trio strategy of father, mother and proband. Clean data with more than 20-fold 145 coverage were about97.88% and about 1041 SNPs on the target region were detected.
146
Noninvasive prenatal diagnosis of fetal MMA 147 The number of SNPs identified ranged from 854 to 1211. The number of 148 informative SNPs which were used to predict the combination of fetal haplotype 149 inherited from mother and father were 122 (20-323) and 113 (24-290). Parental 150 haplotypes were successfully constructed in F01 family. 155 SNPs was used to 151 determine that the fetus inherited wild allele from the father and none SNP supported 152 that fetus inherited the pathogenic haplotype. 86 SNPs was used to determine that the 153 fetus inherited wild allele from the mother and none SNP supported that fetus 154 inherited the pathogenic haplotype. So, the fetus of F01 was normal because of the 155 F1+M1 haplotype (Table 3and Figure 2 ). Based on this strategy, nine fetuses were 156 diagnosed as carriers, nine fetuses were normal and three fetuses were affected by 157 cblC type of MMA due to the compound heterozygous mutation of MMACHC (Table   158 3 and Figure 2 ). 159 Accuracy of NIPT for MMA 160 The Sanger results of fetal DNA were 100% consistent with NIPT result (Table 2) 161 and SNPs deduced using NIPT were 100% consistent with standard haplotypes of 162 fetal gDNA in F01 to F06 (Table S2) . 200X, the accuracy of fetal inherited maternal haplotype was above 99% and when 201 the fetal fraction was between 5% and 10%, the mean number of SNP was about 20 to 202 reach 99% detection accuracy. Previous data showed that the haplotype-based NIPT 203 can be applied to genes with highly homologous sequences like CYP21A2 and SMN1, 204 which is almost impossible to be detected by directly sequencing the pathogenic 205 mutations. 206 MMA is one of the most common disorders of congenital organic acid metabolism. 207 Early prenatal treatment may have an impact on the long-term complications 208 associated with cblC disease. Prior studies have evaluated the effects of prenatal 209 HOCbl administration and the results showed a decrease in the maternal metabolites 210 (Huemer et al. 2005) . Although the haplotype-based strategy was successfully 211 implemented in several autosomal recessive disorders, this has not been applied in 212 MMA till now. The feasibility and accuracy of this method depends on the 213 informative SNPs used to construct the haplotype and the selection of the targeted 214 region, and hence investigation of technical feasibility is necessary for each target 215 disease. Our study initially demonstrated the feasibility of haplotype-based NIPT for 216 MMACHC. In our study, the fetal genotype of 21 families was successfully 217 8 determined using haplotype-assisted NIPT. The result of this study was consistent 218 with the findings of invasive method. Based on these data, the feasibility and accuracy 219 of NIPT of MMA using haplotype strategy has been demonstrated. The sensitivity 220 and specificity rates were both 100%, with 0% failure rate. The accuracy of the fetal 221 alleles inherited from parents deduced by haplotype strategy were almost 100% 222 compared with the standard haplotype obtained by the AF data in families from F01 223 to F06 (Table S2 ). The other family results showed that the haplotype-based NIPT 224 method allowed 100% concordance with the invasive diagnostic approach. 225 In most of the reported cases, the targeted region is always relatively large, and the intervention. We here provided the evidence that the same approach can be applied to 257 other autosomal-recessive disorders, and the overall sensitivity and specificity was 258 100% on 78 patients tested from the previous and our study.
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